Neurobo Pharmaceuticals Inc banner

Neurobo Pharmaceuticals Inc
NASDAQ:MTVA

Watchlist Manager
Neurobo Pharmaceuticals Inc Logo
Neurobo Pharmaceuticals Inc
NASDAQ:MTVA
Watchlist
Price: 1.51 USD 3.42% Market Closed
Market Cap: $7.8m

Dividends

Neurobo Pharmaceuticals Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Neurobo Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Neurobo Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

MTVA Price
Neurobo Pharmaceuticals Inc

Annual Price Range
1.51
52w Low
0.97
52w High
16.5
Price Metrics
Average Annual Return -59.65%
Standard Deviation of Annual Returns 29.14%
Max Drawdown -100%
Shares Statistics
Market Capitalization 16.3m USD
Shares Outstanding 5 160 000
Percentage of Shares Shorted 3.66%

MTVA Return Decomposition
Main factors of price return

Stock Splits

MTVA's latest stock split occurred on Dec 5, 2025

The company executed a 1-for-11 stock split, meaning that for every 11 shares held, investors received 1 new share.

Before the split, MTVA traded at 0.665 per share. Afterward, the share price was about 8.182.

The adjusted shares began trading on Dec 5, 2025. This was stock split number 4 in MTVA's history, following the previous one in Dec 21, 2023.

Pre-Split Price
7.315 0.665
Post-Split Price
8.182
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett